Juvaris BioTherapeutics (United States)
- Research works
- 29 fractional, all time
- Citations
- 480 16.7 per fractional work
- Top-10% rate
- 6.8% all institutions 10.0%
- Open access
- 31% world 40%
- International
- 5% world 18%
Not ranked overall: Juvaris BioTherapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Juvaris BioTherapeutics (United States) work in?
In all years, 48% of research at Juvaris BioTherapeutics (United States) is in Life Sciences, 46% in Health Sciences. Its largest fields are Medicine (46%), Immunology and Microbiology (27%), Biochemistry, Genetics and Molecular Biology (18%). It does 2.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 8 fields, with their numbers
- Life Sciences1448.4%
- Health Sciences1346.3%
- Medicine1346.3%
- Social Sciences13.5%
- Social Sciences13.5%
- Physical Sciences01.7%
- Engineering01.1%
- Environmental Science00.6%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Juvaris BioTherapeutics (United States)?
Ranked on the quality score, Jeff Fairman, Marla J. Lay and Stella Chang lead among researchers whose main affiliation is Juvaris BioTherapeutics (United States).
- 1
Jeff Fairman
United States · #1,432,330 worldwide 1.3k citations · 67 works
- 2
Marla J. Lay
United States · #2,169,104 worldwide 997 citations · 25 works
- 3
Stella Chang
United States · #2,714,999 worldwide 916 citations · 38 works
- 4
Jeffery Fairman
United States · #4,435,329 worldwide 270 citations · 29 works
Which keywords describe research at Juvaris BioTherapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Innate Immunity, Antigen Presentation, Cancer Immunotherapy, Dendritic Cells, Immunity and Antibodies.
- Historical Thinking
- Citizenship Education
- Hepatocellular Carcinoma
- Breast Cancer
- Liver Disease
- Antiviral Therapy
- Chemotherapy
- Antibody Engineering
- Cytokine-Mediated Link
- Therapeutic Antibodies
- Immune Response
- Inflammation
- H1N1
- Genomics
- Antibodies
- Dendritic Cells
- Antigen Presentation
- Innate Immunity
- Epidemiology
- Pathogenesis
- Cancer Immunotherapy
- Immunity
- Vaccines
- Virus
- Influenza
- Pattern Recognition Receptors
- Monoclonal Antibodies
- Toll-like Receptors
- Innate Antiviral Responses
- Fc Receptors
- Angiogenesis
- Global Burden
- Vaccine
- HER2
- Chronic Hepatitis B
- Hepatitis B Virus
- Metastasis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 37 words, with their numbers
- Epidemiology6▲ 5.0×13 topics
- Innate Immunity4▲ 45×2 topics
- Pathogenesis4▲ 28×6 topics
- Antigen Presentation4▲ 154×2 topics
- Cancer Immunotherapy4▲ 106×2 topics
- Dendritic Cells4▲ 114×1 topic
- Immunity4▲ 39×1 topic
- Antibodies4▲ 141×2 topics
- Vaccines4▲ 176×2 topics
- Genomics3▲ 34×2 topics
- Virus3▲ 99×2 topics
- H1N13▲ 312×1 topic
- Influenza3▲ 236×1 topic
- Inflammation3▲ 4.2×6 topics
- Pattern Recognition Receptors3▲ 66×2 topics
- Immune Response2▲ 14×5 topics
- Monoclonal Antibodies2▲ 53×2 topics
- Therapeutic Antibodies2▲ 59×2 topics
- Toll-like Receptors2▲ 45×2 topics
- Cytokine-Mediated Link2▲ 102×1 topic
- Innate Antiviral Responses2▲ 102×1 topic
- Antibody Engineering2▲ 64×1 topic
- Fc Receptors2▲ 64×1 topic
- Chemotherapy2▲ 8.2×2 topics
- Angiogenesis2▲ 13×6 topics
- Antiviral Therapy2▲ 34×3 topics
- Global Burden1▲ 8.9×2 topics
- Liver Disease1▲ 35×2 topics
- Vaccine1▲ 12×5 topics
- Breast Cancer1▲ 17×1 topic
- HER21▲ 152×1 topic
- Hepatocellular Carcinoma1▲ 18×2 topics
- Chronic Hepatitis B1▲ 69×1 topic
- Citizenship Education1▲ 64×1 topic
- Hepatitis B Virus1▲ 69×1 topic
- Historical Thinking1▲ 142×1 topic
- Metastasis1▲ 10×2 topics
Which research topics does Juvaris BioTherapeutics (United States) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Liver physiology and pathology, CRISPR and Genetic Engineering and Cell Adhesion Molecules Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 0 works
- 2 Liver physiology and pathology Hepatology 0 works
- 3 CRISPR and Genetic Engineering Molecular Biology 0 works
- 4 Cell Adhesion Molecules Research Immunology and Allergy 0 works
- 5 Chemokine receptors and signaling Oncology 0 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 7 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 0 works
- 8 Wound Healing and Treatments Rehabilitation 0 works
- 9 Proteoglycans and glycosaminoglycans research Cell Biology 0 works
- 10 Medication Adherence and Compliance Family Practice 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Juvaris BioTherapeutics (United States)'s research output changed?
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Juvaris BioTherapeutics (United States) as a percentage of every work published that year, 0.0000011% in 2024.
Fractional works of Juvaris BioTherapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Pleasanton
- Creative Research Enterprises (United States)
- STS International
- Innovation Research Center
- Blackberry (United States)
- Simpson Strong-Tie (United States)
- Thoratec Corporation (United States)
- Robust Chip (United States)
- 10X Genomics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Juvaris BioTherapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.